Arcturus Therapeutics Holdings, Inc. (ARCT)
15.19
-0.98
(-6.06%)
USD |
NASDAQ |
Aug 28, 16:00
15.18
-0.01
(-0.07%)
Pre-Market: 20:00
Arcturus Therapeutics Holdings Shareholders Equity (Quarterly) : 171.81M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 171.81M |
| March 31, 2026 | 191.36M |
| December 31, 2025 | 213.98M |
| September 30, 2025 | 224.56M |
| June 30, 2025 | 231.05M |
| March 31, 2025 | 233.76M |
| December 31, 2024 | 240.98M |
| September 30, 2024 | 261.87M |
| June 30, 2024 | 258.58M |
| March 31, 2024 | 263.97M |
| December 31, 2023 | 278.51M |
| September 30, 2023 | 280.06M |
| June 30, 2023 | 285.18M |
| March 31, 2023 | 329.25M |
| December 31, 2022 | 270.31M |
| September 30, 2022 | 145.67M |
| June 30, 2022 | 170.72M |
| March 31, 2022 | 184.75M |
| December 31, 2021 | 228.21M |
| September 30, 2021 | 259.13M |
| June 30, 2021 | 305.65M |
| March 31, 2021 | 352.61M |
| December 31, 2020 | 396.55M |
| September 30, 2020 | 261.63M |
| June 30, 2020 | 93.42M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.98M |
| December 31, 2019 | 25.79M |
| September 30, 2019 | 35.90M |
| June 30, 2019 | 21.62M |
| March 31, 2019 | 6.354M |
| December 31, 2018 | 13.64M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 33.79M |
| September 30, 2017 | 38.29M |
| June 30, 2017 | 40.69M |
| March 31, 2017 | 44.23M |
| December 31, 2016 | 47.23M |
| September 30, 2016 | 52.62M |
| June 30, 2016 | 59.78M |
| March 31, 2016 | 64.99M |
| December 31, 2015 | 69.33M |
| September 30, 2015 | 35.08M |
| June 30, 2015 | 38.76M |
| March 31, 2015 | |
| December 31, 2014 | 19.94M |
| September 30, 2014 | 25.96M |
| June 30, 2014 | 35.42M |
| March 31, 2014 | 42.26M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exelixis, Inc. | 1.844B |
| PTC Therapeutics, Inc. | -165.36M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 224.31M |
| Total Liabilities (Quarterly) | 52.50M |
| Debt to Equity Ratio | 0.1335 |
| Current Ratio | 5.879 |
| Net Debt Paydown Yield | 2.07% |